These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Studies of von Willebrand factor: effects of different kinds of carbohydrate oxidases, SH-inhibitors and some other chemical reagents. Fukui H, Mikami S, Okuda T, Murashima N, Takase T. Br J Haematol; 1977 Jun; 36(2):259-70. PubMed ID: 301402 [Abstract] [Full Text] [Related]
24. [Increased von Willebrand activity of low molecular-weight factor VIII following binding to gold granules]. Furlan M, Perret BA, Beck EA. Schweiz Med Wochenschr; 1980 Oct 04; 110(40):1456-8. PubMed ID: 6792697 [Abstract] [Full Text] [Related]
25. Parallel destruction of factor VIII procoagulant activity and an 85,000 dalton protein in highly purified factor VIII/VWF. Cockburn CG, de Beaufre-Apps RJ, Wilson J, Hardisty RM. Thromb Res; 1981 Feb 01; 21(3):295-309. PubMed ID: 6454278 [No Abstract] [Full Text] [Related]
27. Isolation and characterization of a novel serine proteinase complexed with alpha 2-macroglobulin from porcine gastric mucosa. Uchino T, Sakurai Y, Nishigai M, Takahashi T, Arakawa H, Ikai A, Takahashi K. J Biol Chem; 1993 Jan 05; 268(1):527-33. PubMed ID: 7678002 [Abstract] [Full Text] [Related]
36. Effects of thrombin treatment of preparations of factor VIII and the Ca2+-dissociated small active fragment. Cooper HA, Reisner FF, Hall M, Wagner RH. J Clin Invest; 1975 Sep 01; 56(3):751-60. PubMed ID: 1080490 [Abstract] [Full Text] [Related]
37. Effect of protease binding by alpha 2-macroglobulin on intrinsic fluorescence. Straight DL, McKee PA. Biochemistry; 1982 Sep 14; 21(19):4550-6. PubMed ID: 6182901 [Abstract] [Full Text] [Related]